| Entry |
|
|---|
| Name |
Mitoguazone (INN) |
|---|
| Formula |
C5H12N8
|
|---|
| Exact mass |
184.1185
|
|---|
| Mol weight |
184.2024
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic |
|---|
| Target |
|
|---|
| Pathway |
| hsa00270 | Cysteine and methionine metabolism |
| hsa00330 | Arginine and proline metabolism |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX16 Mitoguazone
D07258 Mitoguazone (INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Lyases (EC4)
Carboxy-lyases
AMD1
D07258 Mitoguazone (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 13
1 N1a N 12.6700 -15.6100
2 C2c C 13.8824 -14.9100
3 N1b N 15.0949 -15.6100
4 N2b N 16.3073 -14.9100
5 C2b C 17.5197 -15.6100
6 C2c C 18.7322 -14.9100
7 N2b N 19.9446 -15.6100
8 N1b N 21.1570 -14.9100
9 C2c C 22.3695 -15.6100
10 N1a N 23.5819 -14.9100
11 N2a N 13.8824 -13.5102
12 N2a N 22.3695 -17.0097
13 C1a C 18.7322 -13.5103
BOND 12
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 2
5 5 6 1
6 6 7 2
7 7 8 1
8 8 9 1
9 9 10 1
10 2 11 2
11 9 12 2
12 6 13 1
|
|---|
